TREM 1 antibody(Boehringer Ingelheim International Gmbh)

N/A

Report date: 2023/08/22 17:03:03

Base Information

Drug NameTREM 1 antibody(Boehringer Ingelheim International Gmbh)
Drug Alias NameTriggering Receptor Expressed on Myeloid cells AntibodyTREM 1 antibody(Boehringer Ingelheim International Gmbh)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTriggering receptor expressed on myeloid cells 1 inhibitors
TargetsTriggering receptor expressed on myeloid cells 1
Therapy Area/IndicationsImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim International Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesBoehringer Ingelheim International Gmbh
Inactive CompaniesN/A
Active IndicationsImmune System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A